Amarin Corporation plc (AMRN) Financials
AMRN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 831.7 million | 279.6 million |
2023-09-30 | 839.0 million | 285.9 million |
2023-06-30 | 860.0 million | 290.9 million |
2023-03-31 | 860.2 million | 275.4 million |
AMRN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.2 million | 4.6 million |
2023-09-30 | 7.3 million | 3.6 million |
2023-06-30 | 7.2 million | 1.8 million |
2023-03-31 | -7.0 million | 5.6 million |
AMRN Net Income
No data available :(
AMRN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 321.2 million | - | 8.7 million |
2023-09-30 | 320.7 million | - | 9.0 million |
2023-06-30 | 312.9 million | - | 9.5 million |
2023-03-31 | 304.4 million | - | 9.8 million |
AMRN Shares Outstanding
AMRN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 510959 | 5.1 million | 21.1 million | 22.8 million |
2023-09-30 | 1000 | 5.1 million | 21.4 million | 24.1 million |
2023-06-30 | 23000 | 5.6 million | 18.6 million | 32.3 million |
2023-03-31 | 23000 | 5.7 million | 27.4 million | 32.2 million |
AMRN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 75.4 million | 30.6 million |
2023-09-30 | 66.1 million | 36.2 million |
2023-06-30 | 80.2 million | 37.5 million |
2023-03-31 | 86.0 million | 38.0 million |
AMRN
Price: $0.92
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.15 USD
P/E Ratio: -9.92
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.2 million
Ebitda: -8.2 millionMarket Capitalization: 385.3 million